project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6M; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.83; rna integrity number: 8.5; age at index: 64; days to birth: -23574; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 23574; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1582.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1176; initial weight: 290.0; sample id: 10f2ed03-4e58-41aa-ae19-4d44f57cbdf5; sample submitter id: TCGA-DK-AA6M-01A; portion id: 2bad86d5-3fa0-4d2d-a837-0fa6f189c479; portion submitter id: TCGA-DK-AA6M-01A-11; slide id: 2ec30a99-1a56-4ad8-87be-50933d413b8a; slide submitter id: TCGA-DK-AA6M-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 70.0; section location: TOP;